Breaking News

TekniPlex Healthcare Opens New Production Facility

Significantly expands capacity of its engineered barrier products for flexible packaging.

TekniPlex Healthcare, an advanced materials science company, is extending its North American footprint and expanding global capacity with a new 200,000-square-foot manufacturing plant in Madison, WI – the second TekniPlex Healthcare facility in the city.

Scheduled to open in early 2024, the new facility will operate under the ISO 13485:2016 quality management system, which certifies the ability to provide medical devices and related services to meet customer and regulatory requirements. 

The new facility will feature new manufacturing equipment that will significantly boost the company’s lamination capacity for a broad range of materials including PET, nylon, paper, foil, PE, EAA and ionomer, in both peelable and non-peelable structures. This will help drive shorter lead-times and ensure best in class quality. The laminate and coated products are utilized in a wide variety of applications for the medical device, pharmaceutical, and diagnostics end markets, including flexible foil and plastic pouches, contact lens packaging, blisters, and blister lidding, and sterilizable protective structures for medical devices, accessories, and procedural tools.

“Our business has grown substantially across the medical device, pharmaceutical and diagnostics sectors, and the new Wisconsin location will help TekniPlex provide our customers access to the most advanced process technology and available capacity, solidifying our industry-leading quality and delivery,” said Chris Qualters, CEO of TekniPlex Healthcare. “In addition to providing highly engineered products to ensure patient safety and outcomes, this facility also offers enhancement of our business continuity planning – a highly attractive benefit in an industry where supply risk mitigation is essential to guarantee lifesaving products are available when they are needed.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters